Content area

Abstract

In polycystic kidney disease (PKD), fluid-filled cysts arise from tubules in kidneys and other organs. Human kidney organoids can reconstitute PKD cystogenesis in a genetically specific way, but the mechanisms underlying cystogenesis remain elusive. Here we show that subjecting organoids to fluid shear stress in a PKD-on-a-chip microphysiological system promotes cyst expansion via an absorptive rather than a secretory pathway. A diffusive static condition partially substitutes for fluid flow, implicating volume and solute concentration as key mediators of this effect. Surprisingly, cyst-lining epithelia in organoids polarize outwards towards the media, arguing against a secretory mechanism. Rather, cyst formation is driven by glucose transport into lumens of outwards-facing epithelia, which can be blocked pharmacologically. In PKD mice, glucose is imported through cysts into the renal interstitium, which detaches from tubules to license expansion. Thus, absorption can mediate PKD cyst growth in human organoids, with implications for disease mechanism and potential for therapy development.

In polycystic kidney disease (PKD), fluid-filled cysts arise from tubules. Here the authors show that subjecting organoids to fluid shear stress in a PKD-on-a-chip microphysiological system promotes cyst expansion via an absorptive pathway.

Details

1009240
Title
Glucose absorption drives cystogenesis in a human organoid-on-chip model of polycystic kidney disease
Author
Li, Sienna R. 1 ; Gulieva, Ramila E. 1 ; Helms, Louisa 2 ; Cruz, Nelly M. 1 ; Vincent, Thomas 3 ; Fu, Hongxia 4 ; Himmelfarb, Jonathan 1 ; Freedman, Benjamin S. 5   VIAFID ORCID Logo 

 University of Washington School of Medicine, Division of Nephrology, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Kidney Research Institute, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Institute for Stem Cell and Regenerative Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Department of Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657) 
 University of Washington School of Medicine, Division of Nephrology, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Kidney Research Institute, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Institute for Stem Cell and Regenerative Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Department of Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Department of Laboratory Medicine & Pathology, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657) 
 University of Washington School of Medicine, Division of Nephrology, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Kidney Research Institute, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Institute for Stem Cell and Regenerative Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Department of Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, Department of Bioengineering, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657) 
 University of Washington School of Medicine, Institute for Stem Cell and Regenerative Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Department of Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, Department of Bioengineering, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Division of Hematology, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657) 
 University of Washington School of Medicine, Division of Nephrology, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Kidney Research Institute, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Institute for Stem Cell and Regenerative Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Department of Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington School of Medicine, Department of Laboratory Medicine & Pathology, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, Department of Bioengineering, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657) 
Publication title
Volume
13
Issue
1
Pages
7918
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
Place of publication
London
Country of publication
United States
Publication subject
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
Document type
Journal Article
Publication history
 
 
Online publication date
2022-12-23
Milestone dates
2022-12-09 (Registration); 2022-10-30 (Received); 2022-12-08 (Accepted)
Publication history
 
 
   First posting date
23 Dec 2022
ProQuest document ID
2757228443
Document URL
https://www.proquest.com/scholarly-journals/glucose-absorption-drives-cystogenesis-human/docview/2757228443/se-2?accountid=208611
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Last updated
2024-10-02
Database
ProQuest One Academic